Robert W. Duggan - Jun 6, 2024 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Jun 6, 2024
Transactions value $
$0
Form type
4
Date filed
6/24/2024, 07:33 PM
Previous filing
Jan 4, 2024
Next filing
Jul 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +20K $0.00 20K Jun 6, 2024 Common Stock 20K $14.55 Direct F1
transaction PLSE Stock Option (right to buy) Award $0 +16.2K $0.00 16.2K Jun 6, 2024 Common Stock 16.2K $14.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 6, 2024.
F2 The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2024.